A COVID-19 rapid testing kit developed by the Industrial Technology Research Institute (ITRI) should be ready for mass production as soon as July, officials announced yesterday.
The kit, which works by testing nucleic acids, can produce results within one hour, Deputy Minister of Economic Affairs Lin Chuan-neng (林全能) told a news conference at the Executive Yuan in Taipei, adding that this brings researchers one step closer to developing a vaccine.
The government has invested NT$2.16 billion (US$71.7 million) in the testing, treatment, prevention and research of the disease, National Health Research Institute (NHRI) president Liang Kung-yee (梁賡義) said.
Photo: Chen Yu-fu, Taipei Times
The nation is developing three testing methods, he said.
The first involves testing nucleic acids, which was the focus of the research at the ITRI, he said.
Another method involves testing nucleocapsid and spike proteins, which is being developed by researchers from Academia Sinica and the NHRI, he said.
That test could produce results in 15 to 20 minutes, and might also be ready for mass production by July, he said.
Nearly 20 companies attended an information session held by Academia Sinica and the NHRI to present their research, five of which expressed an interest in producing the test, he said.
The third type involves testing antibodies produced by the human body, and could be used on patients in recovery, he said.
Research on this method, which can produce results in 15 to 20 minutes, is being done at Chang Gung University in Taoyuan, he said, adding that mass production could commence in October.
“It is possible that COVID-19 will mutate into a form of influenza,” Liang said, adding that a vaccine and effective medication for treatment would be crucial if that happens.
The NHRI and Academia Sinica had already produced a 10g sample of their testing compound and could go into production now, he said.
Researchers are also experimenting with a combination of the Japanese antiviral drug favipiravir and other drugs for the treatment of patients with mild to moderate symptoms, he said.
The drug’s effectiveness against COVID-19 is being compared with that of another antiviral medication, remdesivir, and a synthesized drug has shown promise, he said, adding that companies have shown an interest in producing it.
A third drug, quinine — which is commonly used to treat malaria and babesiosis — has also shown promise in the treatment of COVID-19 patients with mild symptoms, he said.
Moreover, researchers have been separately developing six possible vaccines since late January and hope to arrive at a solution by the end of next month.
“If everything goes smoothly, we could see clinical trials by the end of the year,” he said.
“Several countries have expressed hope to work with Taiwan to produce a vaccine and rapid test,” he said.
UKRAINE, NVIDIA: The US leader said the subject of Russia’s war had come up ‘very strongly,’ while Jenson Huang was hoping that the conversation was good Chinese President Xi Jinping (習近平) and US President Donald Trump had differing takes following their meeting in Busan, South Korea, yesterday. Xi said that the two sides should complete follow-up work as soon as possible to deliver tangible results that would provide “peace of mind” to China, the US and the rest of the world, while Trump hailed the “great success” of the talks. The two discussed trade, including a deal to reduce tariffs slapped on China for its role in the fentanyl trade, as well as cooperation in ending the war in Ukraine, among other issues, but they did not mention
Japanese Prime Minister Sanae Takaichi yesterday lavished US President Donald Trump with praise and vows of a “golden age” of ties on his visit to Tokyo, before inking a deal with Washington aimed at securing critical minerals. Takaichi — Japan’s first female prime minister — pulled out all the stops for Trump in her opening test on the international stage and even announced that she would nominate him for a Nobel Peace Prize, the White House said. Trump has become increasingly focused on the Nobel since his return to power in January and claims to have ended several conflicts around the world,
CALL FOR SUPPORT: President William Lai called on lawmakers across party lines to ensure the livelihood of Taiwanese and that national security is protected President William Lai (賴清德) yesterday called for bipartisan support for Taiwan’s investment in self-defense capabilities at the christening and launch of two coast guard vessels at CSBC Corp, Taiwan’s (台灣國際造船) shipyard in Kaohsiung. The Taipei (台北) is the fourth and final ship of the Chiayi-class offshore patrol vessels, and the Siraya (西拉雅) is the Coast Guard Administration’s (CGA) first-ever ocean patrol vessel, the government said. The Taipei is the fourth and final ship of the Chiayi-class offshore patrol vessels with a displacement of about 4,000 tonnes, Lai said. This ship class was ordered as a result of former president Tsai Ing-wen’s (蔡英文) 2018
GLOBAL PROJECT: Underseas cables ‘are the nervous system of democratic connectivity,’ which is under stress, Member of the European Parliament Rihards Kols said The government yesterday launched an initiative to promote global cooperation on improved security of undersea cables, following reported disruptions of such cables near Taiwan and around the world. The Management Initiative on International Undersea Cables aims to “bring together stakeholders, align standards, promote best practices and turn shared concerns into beneficial cooperation,” Minister of Foreign Affairs Lin Chia-lung (林佳龍) said at a seminar in Taipei. The project would be known as “RISK,” an acronym for risk mitigation, information sharing, systemic reform and knowledge building, he said at the seminar, titled “Taiwan-Europe Subsea Cable Security Cooperation Forum.” Taiwan sits at a vital junction on
RSS